Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.54 |
| ▸ | HTR2C | P28335 | 3/20 | 0.53 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5489875 | 0.83 | HTR2C (0.56) | HRH3HTR2CDRD3HTR1AMTNR1B | |
| SCHEMBL22053182 | 0.80 | CHRNA7 (0.57) | HTR2CDRD3HTR1AMTNR1BCHRNA7 | |
| SCHEMBL31011171 | 0.80 | CHRNA7 (0.57) | HTR2CDRD3HTR1AMTNR1BCHRNA7 | |
| SCHEMBL6001969 | 0.80 | CHRNA7 (0.68) | HTR2CDRD3HTR1ACHRNA7OPRM1 | |
| SCHEMBL7678292 | 0.76 | CHRNA7 (0.67) | HTR2CDRD3HTR1ACHRNA7OPRM1 | |
| SCHEMBL7680425 | 0.76 | CHRNA7 (0.67) | HTR2CDRD3HTR1ACHRNA7OPRM1 | |
| SCHEMBL7680070 | 0.76 | CHRNA7 (0.67) | HTR2CDRD3HTR1ACHRNA7OPRM1 | |
| SCHEMBL6002219 | 0.76 | CHRNA7 (0.66) | HTR2CDRD3HTR1ACHRNA7OPRM1 | |
| SCHEMBL5473949 | 0.75 | HTR2C (0.61) | HTR2CDRD3HTR1AMTNR1BOPRM1 | |
| SCHEMBL9282435 | 0.75 | POLB (0.56) | HTR2CDRD3HTR1AMTNR1BCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064706-A1 | Piperidine Derivatives as Histamine H3 Receptor Ligands | ASTRAZENECA AB (SE) | 2008-03-13 | — | — | US | disclosed |
| US-20080064706-A1 | Piperidine Derivatives as Histamine H3 Receptor Ligands | ASTRAZENECA AB (SE) | 2008-03-13 | — | — | US | disclosed |
| US-20080064706-A1 | Piperidine Derivatives as Histamine H3 Receptor Ligands | ASTRAZENECA AB (SE) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064706-A1 | Piperidine Derivatives as Histamine H3 Receptor Ligands | HRH3, HRH1, HRH4 | HRH3 1/4885HTR2C 21/4885FNTA 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.